Immunotherapy utilization patterns in metastatic bladder cancer: assessing insurance status as a modifiable factor associated with failure to receive novel therapies
Urologic Oncology: Seminars and Original Investigations（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要